Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers​", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Christensen AH(2024) Can sinoatrial reinnervation improve survival after heart transplantation? J Heart Lung Transplant(in press) DOI 10.1016/j.healun.2024.11.004, PubMed 39557315
Ankill J, Zhao Z, Tekpli X, Kure EH, Kristensen VN, Mathelier A, Fleischer T(2024) Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation PLoS Comput Biol, 20(11), e1012565(in press) DOI 10.1371/journal.pcbi.1012565, PubMed 39556603
Kleppe A, Lindemann K, Kildal W, Tobin KAR, Pradhan M, Vlatkovic L, Isaksen MX, Danielsen HE, Askautrud HA, Kristensen GB(2024) Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer Gynecol Oncol, 192, 80-88(in press) DOI 10.1016/j.ygyno.2024.11.005, PubMed 39549540